RecruitingNot applicableNCT06376110
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
Studying Anterior cutaneous nerve entrapment syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Austin Institute for Clinical Research
- Principal Investigator
- Edward Lain, MD, MBA, M.DAustin Institute for Clinical Research
- Intervention
- Topical Antioxidant Serum(drug)
- Enrollment
- 10 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Collaborators
SkinCeuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06376110 on ClinicalTrials.govOther trials for Anterior cutaneous nerve entrapment syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07544251Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.Integrative Skin Science and Research
- RECRUITINGNANCT07406893Reduction of Bacterial Seeding in Total Shoulder ArthroplastySt. Louis University
- ACTIVE NOT RECRUITINGNCT07205107Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne VulgarisBausch Health Americas, Inc.
- RECRUITINGNANCT07056673Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris StudyShenyang Medical College
- RECRUITINGPHASE3NCT06447480Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color PatientsCentre Hospitalier Universitaire de Nice
- RECRUITINGNCT06850389PMCF Investigation of Medical Device ChitoCare® MedicalPrimex ehf
- RECRUITINGPHASE1NCT06989840Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without AcneSagimet Biosciences Inc.
- RECRUITINGEARLY PHASE1NCT07007078Efficacy of Dihydroartemisinin for Treating Acne VulgarisShanghai Zhongshan Hospital
See all trials for Anterior cutaneous nerve entrapment syndrome →